Endoglin based in vivo near-infrared fluorescence imaging of tumor models in mice using activatable liposomes.

[1]  I. Hilger,et al.  Activatable bispecific liposomes bearing fibroblast activation protein directed single chain fragment/Trastuzumab deliver encapsulated cargo into the nuclei of tumor cells and the tumor microenvironment simultaneously. , 2017, Acta biomaterialia.

[2]  I. Hilger,et al.  A fast and effective determination of the biodistribution and subcellular localization of fluorescent immunoliposomes in freshly excised animal organs , 2017, BMC Biotechnology.

[3]  Ingrid Hilger,et al.  Potential of activatable FAP-targeting immunoliposomes in intraoperative imaging of spontaneous metastases. , 2016, Biomaterials.

[4]  I. Hilger,et al.  Fluorescence-quenching of a liposomal-encapsulated near-infrared fluorophore as a tool for in vivo optical imaging. , 2015, Journal of visualized experiments : JoVE.

[5]  G. Winter,et al.  Thermosensitive liposomal drug delivery systems: state of the art review , 2014, International journal of nanomedicine.

[6]  I. Hilger,et al.  In vivo near-infrared fluorescence imaging of FAP-expressing tumors with activatable FAP-targeted, single-chain Fv-immunoliposomes. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[7]  M. Letarte,et al.  Review: the enigmatic role of endoglin in the placenta. , 2014, Placenta.

[8]  W. Kaiser,et al.  Liposomal encapsulation of a near-infrared fluorophore enhances fluorescence quenching and reliable whole body optical imaging upon activation in vivo. , 2013, Small.

[9]  N. Oku,et al.  Enhanced Active Targeting via Cooperative Binding of Ligands on Liposomes to Target Receptors , 2013, PloS one.

[10]  F. Salvatore,et al.  Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[11]  Meng Yang,et al.  Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha. , 2012, Bioconjugate chemistry.

[12]  H. Shmeeda,et al.  Pharmacological basis of pegylated liposomal doxorubicin: impact on cancer therapy. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  Viness Pillay,et al.  A Review on Composite Liposomal Technologies for Specialized Drug Delivery , 2011, Journal of drug delivery.

[14]  J. López-Novoa,et al.  The emerging role of TGF-beta superfamily coreceptors in cancer. , 2009, Biochimica et biophysica acta.

[15]  P. Choyke,et al.  H-type dimer formation of fluorophores: a mechanism for activatable, in vivo optical molecular imaging. , 2009, ACS chemical biology.

[16]  R. Kontermann,et al.  Murine endoglin-specific single-chain Fv fragments for the analysis of vascular targeting strategies in mice. , 2008, Journal of immunological methods.

[17]  George Zonios,et al.  Melanin optical properties provide evidence for chemical and structural disorder in vivo. , 2008, Optics express.

[18]  L. Ellis,et al.  Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy , 2008, Clinical Cancer Research.

[19]  T. Allen,et al.  Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[20]  A. Fahr,et al.  Drug delivery strategies for poorly water-soluble drugs , 2007, Expert opinion on drug delivery.

[21]  R. Kontermann,et al.  Improved Pharmacokinetics of Recombinant Bispecific Antibody Molecules by Fusion to Human Serum Albumin* , 2007, Journal of Biological Chemistry.

[22]  W. Aird,et al.  Vascular endocan is preferentially expressed in tumor endothelium. , 2006, Microvascular research.

[23]  R. Kontermann,et al.  Generation of immunoliposomes using recombinant single-chain Fv fragments bound to Ni-NTA-liposomes , 2005, Journal of drug targeting.

[24]  R. Kontermann,et al.  Isolation of endothelial cell-specific human antibodies from a novel fully synthetic scFv library. , 2004, Biochemical and biophysical research communications.

[25]  S. O'dwyer,et al.  Perfusion of 99Tcm‐labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target , 2004, International journal of cancer.

[26]  R. M. Cook,et al.  Intramolecular dimers: a new design strategy for fluorescence-quenched probes. , 2003, Chemistry.

[27]  M. Maio,et al.  Endoglin (CD105): a target for anti-angiogenetic cancer therapy. , 2003, Current drug targets.

[28]  R. Brekken,et al.  Strategies for vascular targeting in tumors , 2002, International journal of cancer.

[29]  L. Zardi,et al.  Lack of specificity of endoglin expression for tumor blood vessels , 2001, International journal of cancer.

[30]  T. Allen,et al.  In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. , 2001, Biochimica et biophysica acta.

[31]  M. Maio,et al.  Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  Semi Kim,et al.  Regulation of Angiogenesis in Vivo by Ligation of Integrin α5β1 with the Central Cell-Binding Domain of Fibronectin , 2000 .

[33]  M. Barcos,et al.  Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  E Biganzoli,et al.  Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  E. Butcher,et al.  Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-beta ligand. , 1994, Gene.

[36]  J. Healey,et al.  Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Ito,et al.  Optical absorption and fluorescence spectroscopy studies of ground state melanin-cationic porphyrins complexes. , 1992, Biophysical chemistry.

[38]  J. Denekamp,et al.  Endothelial proliferation in tumours and normal tissues: continuous labelling studies. , 1984, British Journal of Cancer.

[39]  G. Salzano,et al.  Multifunctional Liposomes. , 2017, Methods in molecular biology.

[40]  J. Feldman.  A MATHEMATICAL MODEL FOR TUMOR VOLUME EVALUATION USING TWO-DIMENSIONS , 2010 .

[41]  W. Aird.  Molecular heterogeneity of tumor endothelium , 2008, Cell and Tissue Research.

[42]  Vasilis Ntziachristos,et al.  Shedding light onto live molecular targets , 2003, Nature Medicine.

[43]  E. Moase,et al.  Use of the post-insertion method for the formation of ligand-coupled liposomes. , 2002, Cellular & molecular biology letters.